Abstract

This study analyzes the association of excessive energy intake and caloric restriction with breast cancer (BC) risk taking into account the individual energy needs of Spanish women. We conducted a multicenter matched case-control study where 973 pairs completed lifestyle and food frequency questionnaires. Expected caloric intake was predicted from a linear regression model in controls, including calories consumed as dependent variable, basal metabolic rate as an offset and physical activity as explanatory. Overeating and caloric restriction were defined taking into account the 99% confidence interval of the predicted value. The association with BC risk, overall and by pathologic subtype, was evaluated using conditional and multinomial logistic regression models. While premenopausal women that consumed few calories (>20% below predicted) had lower BC risk (OR = 0.36; 95% CI = 0.21–0.63), postmenopausal women with an excessive intake (≥40% above predicted) showed an increased risk (OR = 2.81; 95% CI = 1.65–4.79). For every 20% increase in relative (observed/predicted) caloric intake the risk of hormone receptor positive (p-trend < 0.001) and HER2+ (p-trend = 0.015) tumours increased 13%, being this figure 7% for triple negative tumours. While high energy intake increases BC risk, caloric restriction could be protective. Moderate caloric restriction, in combination with regular physical activity, could be a good strategy for BC prevention.

Details

Title
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study
Author
Lope Virginia 1 ; Martín, Miguel 2   VIAFID ORCID Logo  ; Castelló Adela 1 ; Ruiz, Amparo 3 ; Casas, Ana Mª 4 ; Baena-Cañada, José Manuel 5 ; Antolín Silvia 6 ; Ramos-Vázquez, Manuel 7 ; García-Sáenz, José Ángel 8 ; Muñoz Montserrat 9 ; Lluch Ana 10 ; de Juan-Ferré Ana 11 ; Jara, Carlos 12 ; Sánchez-Rovira, Pedro 13 ; Antón, Antonio 14 ; Chacón, José Ignacio 15 ; Arcusa Angels 16 ; Jimeno Mª Angeles 17 ; Bezares Susana 17 ; Vioque Jesús 18 ; Carrasco, Eva 17 ; Pérez-Gómez Beatriz 1   VIAFID ORCID Logo  ; Pollán Marina 1 

 Carlos III Institute of Health, National Center for Epidemiology, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); CIBERESP, Consortium for Biomedical Research in Epidemiology & Public Health, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); CIBERONC-ISCIII, Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain (GRID:grid.410526.4) (ISNI:0000 0001 0277 7938) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Instituto Valenciano de Oncología, Valencia, Spain (GRID:grid.418082.7) (ISNI:0000 0004 1771 144X) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Hospital Virgen del Rocío, Sevilla, Spain (GRID:grid.411109.c) (ISNI:0000 0000 9542 1158) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Hospital Puerta del Mar, Cádiz, Spain (GRID:grid.411342.1) (ISNI:0000 0004 1771 1175) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Complejo Hospitalario Universitario A Coruña, A Coruña, Spain (GRID:grid.411066.4) (ISNI:0000 0004 1771 0279) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Centro Oncológico de Galicia, A Coruña, Spain (GRID:grid.418394.3) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Hospital Clínico San Carlos, Madrid, Spain (GRID:grid.411068.a) (ISNI:0000 0001 0671 5785) 
 GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Hospital Clinic i Provincial, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413) 
10  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); CIBERONC-ISCIII, Centro de Investigación Biomédica en Red de Oncología, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Hospital Clínico de Valencia, Valencia, Spain (GRID:grid.411308.f) 
11  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Hospital Marqués de Valdecilla, Santander, Spain (GRID:grid.411325.0) (ISNI:0000 0001 0627 4262) 
12  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Fundación Hospital de Alcorcón, Madrid, Spain (GRID:grid.411316.0) (ISNI:0000 0004 1767 1089) 
13  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Complejo Hospitalario de Jaén, Jaén, Spain (GRID:grid.418878.a) (ISNI:0000 0004 1771 208X) 
14  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Hospital Universitario Miguel Servet, Zaragoza, Spain (GRID:grid.411106.3) (ISNI:0000 0000 9854 2756) 
15  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Hospital Virgen de la Salud, Toledo, Spain (GRID:grid.413514.6) (ISNI:0000 0004 1795 0563) 
16  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7); Consorci Sanitari de Terrassa, Barcelona, Spain (GRID:grid.476208.f) (ISNI:0000 0000 9840 9189) 
17  GEICAM Spanish Breast Cancer Group, Madrid, Spain (GRID:grid.476406.7) 
18  CIBERESP, Consortium for Biomedical Research in Epidemiology & Public Health, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universidad Miguel Hernández, ISABIAL, Alicante, Spain (GRID:grid.26811.3c) (ISNI:0000 0001 0586 4893) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2188972119
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.